Molecular biomarkers for predicting complete response to preoperative chemoradiation in people with locally advanced rectal cancer
This is a protocol for a Cochrane Review (prognosis). The objectives are as follows: Primary objectives To identify and estimate the prognostic value of molecular biomarkers as predictors of pathological complete response to neoadjuvant chemoradiotherapy in people with locally advanced rectal cancer. summarises the review question in population, index prognostic factor, comparator prognostic factor(s), outcome, timing, and setting (PICOTS) format. [Table: see text] [Figure: see text] Secondary objectives To explore the following biomarker measurement, treatment, and study design factors as possible sources of heterogeneity in the association between the prognostic factor and pathological response: type of assay/measurement method, biomarker positivity criteria or cut-off point, chemotherapy regimen, and radiotherapy regimen.
Authors
- Maija R.J. Kohonen‐Corish (ORCID: https://orcid.org/0000-0002-4073-1479)
- Sarah J. Lord (ORCID: https://orcid.org/0000-0003-2763-5949)
- Catherine E Caldon
- Matthew J. Morgan
- Penelope A De Lacavalerie
Institutions
- The University of Sydney (AU)
- Garvan Institute of Medical Research (AU)
- Bankstown Lidcombe Hospital (AU)
- Woolcock Institute of Medical Research (AU)
- UNSW Sydney (AU)
- Prince of Wales Hospital (AU)
- St Vincent's Clinic (AU)
- National Health and Medical Research Council (AU)
- Western Sydney University (AU)
- The University of Notre Dame Australia (AU)
- Macquarie University (AU)
Publication Details
- Journal
- Cochrane Database of Systematic Reviews
- Published
- 2024-11-29
- DOI
- https://doi.org/10.1002/14651858.cd014718
- Citations
- 1
- Primary Topic
- Colorectal Cancer Surgical Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.28